Primary Job Title Shields Warren-Mallinckrodt Professor, Medical Research Primary Organization 
Harvard Medical School
Gender Male
Robert C. Moellering, Jr.(MD) is the Member Of The Board Of Directors at Nanobio.
Dr. Moellering brings over 30 years of extensive medical experience to the NanoBio Board. He is broadly recognized as a worldwide expert in the areas of infectious diseases and antimicrobial technologies.
Dr. Moellering is the Shields Warren-Mallinckrodt
Professor of Medical Research at Harvard Medical School.
From 1998 to 2005, he served as the Herrman Ludwig Blumgart Professor of Medicine at Harvard Medical School and Physician-in-Chief and Chairman of the Department of Medicine at the Beth Israel Deaconess Medical Center.
Dr. Moellering received his M.D. Degree cum laude from Harvard Medical School and continued his distinguished career at Massachusetts General Hospital and Harvard Medical School.
He has also served as President and CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center.
Dr. Moellering has been actively involved in research on the mechanisms of action and mechanisms of resistance of antimicrobial agents for the past 25 years. He has defined some of the important mechanisms of interaction of antimicrobial agents, which have been reported extensively in scientific journals.
He is the Editor-in-Chief Emeritus of Antimicrobial Agents and Chemotherapy,
Editor of Infectious Disease Clinics of North America,
Editor of the European Journal of Clinical Microbiology and Infectious Diseases.
